piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner.

MLA

Xie, Qi, et al. “PiRNA-14633 Promotes Cervical Cancer Cell Malignancy in a METTL14-Dependent M6A RNA Methylation Manner.” Journal of Translational Medicine, vol. 20, no. 1, Jan. 2022, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s12967-022-03257-2.

APA

Xie, Q., Li, Z., Luo, X., Wang, D., Zhou, Y., Zhao, J., Gao, S., Yang, Y., Fu, W., Kong, L., & Sun, T. (2022). piRNA-14633 promotes cervical cancer cell malignancy in a METTL14-dependent m6A RNA methylation manner. Journal of Translational Medicine, 20(1), 1–16. https://doi.org/10.1186/s12967-022-03257-2

Chicago

Xie, Qi, Zhen Li, Xiao Luo, Dan Wang, Yao Zhou, Jingge Zhao, Suhua Gao, et al. 2022. “PiRNA-14633 Promotes Cervical Cancer Cell Malignancy in a METTL14-Dependent M6A RNA Methylation Manner.” Journal of Translational Medicine 20 (1): 1–16. doi:10.1186/s12967-022-03257-2.